1 – 2 yrs
12 months
12,500 Rs./Month
Biomedical Engineers are required for Sales and Marketting of Healthcare products in Delhi
Freshers can also apply
Requirement Email
We are looking for Biomedical Engineers/ BE (Diploma) in Electrical/ MBA/ ITI Electrical for Marketing of the above in Delhi.
Freshers are welcome.
Basic requirement: Good communication skills, Ready to work in Marketing and hard working.
Good renumeration is guaranteed.
Apply with your Latest updated resume to ( Please note, Subject of email: Biomedical Job Advertised on Biomedikal.in)
Recent Update
Please note: Demand Draft should be drawn in favor of “The Principal, Rajalakshmi Engineering College” payable at Chennai.
Rajalakshmi Engineering college is conducting a summer program for engineers esp Biomedical Engineers
In this program they will be teaching the softwares like
Program Dates : 10th- 12th June 2013
Hippocampus, the part of the brain with a major role in forming long-term memories
A memory device may be implanted in a small number of human volunteers within two years and the device might become available to anyone within five to ten years. A maverick neuroscientist, Theodore Berger, believes he has deciphered the code by which the brain forms long-term memories.
Theodore Berger, a biomedical engineer and neuroscientist at the University of Southern California in Los Angeles, envisions a day in the not too distant future when a patient with severe memory loss can get help from an electronic implant.
Colorectal cancer kills some 500,000 people every year. It is the second most common form of cancer in women and the third most common in men.
Some 80 per cent of these cancers start as colorectal polyps, which are relatively easy to spot and remove. But conventional colonoscopies are time-consuming, invasive and expensive, so various groups are looking for better ways to do the job.
For many who suffer from chronic migraines, nothing can reliably prevent or dull the debilitating headaches that may strike as often as every other day.
A biopharmaceutical company in Bothell, Washington, may have a solution. It hopes that a monthly injection of an antibody that blocks a well-known migraine-triggering protein will prevent these headaches.
The company, called Alder Biopharmaceuticals, is testing the efficacy of the drug in a clinical study of 160 patients, each of whom has between four and 14 migraines per month; Alder expects the results of the study to be in this fall.